We've found
27,461
archived clinical trials in
Hematology
We've found
27,461
archived clinical trials in
Hematology
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Updated: 10/19/2017
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
ADVATE Post Authorization Safety Surveillance
Updated: 10/19/2017
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Updated: 10/19/2017
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Click here to add this to my saved trials